Watson Pharmaceuticals to Acquire Actavis for $5.6 Billion
08:59 AM | April 26, 2012 | Deepti Ramesh
Watson Pharmaceuticals (Parsippany, NJ), a leading manufacturer of generic, branded and biologic pharmaceutical products, and privately held generic pharmaceuticals company Actavis (Zug, Switzerland)...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.